The BENCHISTA study analyzes survival disparities in six childhood solid tumors across 27 countries, revealing that while stage at diagnosis influences outcomes, significant international survival variations persist for Ewing sarcoma and medulloblastoma even after stage adjustment, suggesting the need for broader healthcare system improvements.